Cytoskeletal genes regulation by chronic morphine treatment in rat striatum

Cynthia Marie-Claire1, Cindie Courtin, Bernard P Roques

  • 1Departement de Pharmacochimie Moleculaire et Structurale, Universite Rene Descartes-Paris V, Paris, France. marie@pharmacie.univ-paris5.fr

Insights

Chronic morphine use alters cytoskeleton proteins in rat brains. This study found changes in mRNA and protein levels for key cytoskeletal components, indicating neuroadaptation.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Pharmacology

Background:

  • Morphine is known to affect cellular processes.
  • Cytoskeletal proteins play crucial roles in neuronal function, trafficking, and structural integrity.

Purpose of the Study:

  • To investigate the impact of chronic morphine administration on the expression of 14 key cytoskeletal proteins in the rat striatum.
  • To determine if changes in mRNA levels correlate with protein expression levels.

Main Methods:

  • Real-time quantitative polymerase chain reaction (RT-qPCR) was used to measure mRNA levels.
  • Immunoblot analyses were performed to assess protein expression levels.

Main Results:

  • Chronic morphine treatment modulated the mRNA levels of seven out of 14 tested genes.
  • Glial fibrillary acidic protein (Gfap) and activity-regulated cytoskeleton-associated protein (Arc) mRNA were upregulated.
  • Growth associated protein (Gap43), clathrin heavy chain (Cltc), alpha-tubulin, Tau, and stathmin mRNA were downregulated.
  • Protein levels generally correlated with mRNA changes, except for Gap43.

Conclusions:

  • Neuroadaptation to chronic morphine involves significant modifications in the expression of cytoskeletal and associated proteins in the rat striatum.
  • These findings highlight the molecular mechanisms underlying the brain's response to chronic opioid exposure.

Related Concept Videos